Literature DB >> 3771600

A reappraisal of metatarsus adductus and skewfoot.

E E Berg.   

Abstract

The hypothesis that the treatment of adduction of the fore part of the foot in the child is altered by an associated deformity of the middle or the hind part, or both, was tested in a prospective study of eighty-four patients (124 feet). Radiographic classification delineated four configurations of adduction of the foot, based on varying relationships of the fore, middle, and hind parts of the foot. Twenty-two (43 per cent) of the feet with adduction of the fore part alone (simple metatarsus adductus) required no treatment, as compared with eighteen feet (24 per cent) with the other types of adduction (p less than 0.03). The patients with a complex skew-foot deformity required twice as long a period of cast treatment as those with simple metatarsus adductus (p = 0.0001). On evaluation at a minimum follow-up of two years, only one of the 124 feet had residual adduction of the fore part of the foot, as determined radiographically. It was also found that the use of the Denis-Browne bar was accompanied by an increased incidence of flat-foot deformity at follow-up.

Entities:  

Mesh:

Year:  1986        PMID: 3771600

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  3 in total

Review 1.  Ultrasound evaluation of foot deformities in infants.

Authors:  Marie-Claude Miron; Guy Grimard
Journal:  Pediatr Radiol       Date:  2015-10-12

2.  Combined lateral and transcuneiform without medial osteotomy for residual clubfoot for children.

Authors:  Arjandas Mahadev; Ismail Munajat; Azura Mansor; James H P Hui
Journal:  Clin Orthop Relat Res       Date:  2009-02-27       Impact factor: 4.176

Review 3.  The identification and appraisal of assessment tools used to evaluate metatarsus adductus: a systematic review of their measurement properties.

Authors:  Nicole Marshall; Emily Ward; Cylie M Williams
Journal:  J Foot Ankle Res       Date:  2018-06-01       Impact factor: 2.303

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.